Biogen (BIIB) Shares Shoot Up 40% after FDA Approval of Its Alzheimer’s Drug
Regardless of the heated debates on the drug’s efficacy, Biogen (BIIB) stock has taken an uptrend, with the latest gain being the 4th in a row of gains in the past week.
Biogen (BIIB) Stock Up 44% After Signs of FDA Nod for Alzheimer’s Drug
The FDA called the latest results of the test for Biogen’s Alzheimer’s drug Aducanumab as “highly persuasive” and suggested that it is likely to approve the drug by the coming Friday.
Warren Buffett Finds ‘Elephant’ with Giant Stake in Apple (AAPL) Stocks
By
Tolu Ajiboye
Over the last few years, the giant stake in Apple (AAPL) stocks acquired by a prominent investor Warren Buffett has paid off significantly with more than 80% returns.